Distal extremity necrosis as a manifestation of cutaneous polyarteritis nodosa: Case report and review of the acute management of a pediatric patient

Pediatric Dermatology

Volumn 29, Issue 4, 2012, Pages 473-478

  Williams, Victoria L ^a   Guirola, Ricardo ^b   Flemming, Kristy ^a   Modi, Gunjan M ^a   Rosales, Cecilia ^c   Deguzman, Marietta M ^a  

^a Departments of Dermatology   (United States)

^b Departments of Rheumatology   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BOSENTAN; CYCLOPHOSPHAMIDE; GABAPENTIN; GLYCERYL TRINITRATE; HYDROXYCHLOROQUINE; ILOPROST; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; NIFEDIPINE; PENICILLIN G; PENTOXIFYLLINE; PREDNISONE; SILDENAFIL;

ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CUTANEOUS POLYARTERITIS NODOSA; DISEASE CONTROL; DISTAL EXTREMITY NECROSIS; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; ISCHEMIA; LIMB DISEASE; LIMB PERFUSION; NECROSIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REPERFUSION; SCHOOL CHILD; SKIN BIOPSY; SKIN ULCER;

ACUTE DISEASE; CHILD; EXTREMITIES; FEMALE; GANGRENE; HUMANS; NECROSIS; POLYARTERITIS NODOSA; SKIN ULCER;

EID: 84863447664     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01515.x     Document Type: Article

References (18)

1. Fathalla BM, Miller L, Brady S, et al., Cutaneous polyarteritis nodosa in children. J Am Acad Dermatol 2005; 53: 724-728. (Pubitemid 41399955)
2. Ginarte M, Pereiro M, Toribio J,. Cutaneous polyarteritis nodosa in a child. Pediatr Dermatol 1998; 15: 103-107. (Pubitemid 28173650)
3. Trueb RM, Hurlimann AF, Burg G,. [Periarteritis nodosa cutanea. 20 years follow-up with leg pain, Raynaud syndrome and nail changes]. Hautarzt 1995; 46: 568-572.
4. Gonzalez-Fernandez MA, Garcia-Consuegra J,. Polyarteritis nodosa resistant to conventional treatment in a pediatric patient. Ann Pharmacother 2007; 41: 885-890. (Pubitemid 46752669)
5. Andreu-Sanchez JL, Martin-Santos JM, Isasi-Zaragoza C, et al., Raynaud's phenomenon as initial manifestation of cutaneous polyarteritis nodosa. Ann Rheum Dis 1991; 50: 48-50.
6. Mocan H, Mocan MC, Peru H, et al., Cutaneous polyarteritis nodosa in a child and a review of the literature. Acta Paediatr 1998; 87: 351-353. (Pubitemid 28134281)
7. Kumar L, Thapa BR, Sarkar B, et al., Benign cutaneous polyarteritis nodosa in children below 10 years of age-a clinical experience. Ann Rheum Dis 1995; 54: 134-136.
8. Warner PM, Kagan RJ, Yakuboff KP, et al., Current management of purpura fulminans: a multicenter study. J Burn Care Rehabil 2003; 24: 119-126. (Pubitemid 36604419)
9. Cassidy JT, Petty RE,. Polyarteritis Nodosa and related vasculitides. In:, Cassisy JT, Petty RE, Laxer RM, Lindsley CB, eds. Textbook of pediatric rheumatology, 5th ed. Philidelphia, PA: Elsevier Saunders, 2006: 512-520.
10. Wallace JS, Hall JC,. Use of drug therapy to manage acute cutaneous necrosis of the skin. J Drugs Dermatol 2010; 9: 341-349.
11. Adatia I, Shekerdemian L,. The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists. Pediatr Crit Care Med 2010; 11: S46-S52.
12. Cho C, Pruitt AW,. Therapeutic uses of calcium channel-blocking drugs in the young. Am J Dis Child 1986; 140: 360-366. (Pubitemid 16104492)
13. Herrick AL,. Therapy: a local approach to Raynaud phenomenon. Nat Rev Rheumatol 2009; 5: 246-247.
14. Gore J, Silver R,. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Ann Rheum Dis 2005; 64: 1387. (Pubitemid 41206274)
15. Zargari O,. Pentoxifylline: a drug with wide spectrum applications in dermatology. Dermatol Online J 2008; 14: 2.
16. Zulian F, Corona F, Gerloni V, et al., Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases. Rheumatology (Oxford) 2004; 43: 229-233. (Pubitemid 38219681)
17. Dhillon S,. Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis. Drugs 2009; 69: 2005-2024.
18. Gedalia A, Correa H, Kaiser M, et al., Case report: steroid sparing effect of intravenous gamma globulin in a child with necrotizing vasculitis. Am J Med Sci 1995; 309: 226-228.